
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Merck KGaA
Market Cap: €45.2b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€104.05
7D
-3.5%
1Y
-20.8%
SCHOTT Pharma KGaA
Market Cap: €2.0b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€12.96
7D
-4.4%
1Y
-44.7%
Bayer
Market Cap: €37.7b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€38.39
7D
-0.6%
1Y
59.4%
Evotec
Market Cap: €762.0m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.30
7D
2.9%
1Y
-32.0%
Formycon
Market Cap: €301.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€17.06
7D
-9.6%
1Y
-36.0%